Loading...
Loading...
India's acyclovir imports from UNITED STATES total $95.7K across 52 shipments from 15 foreign suppliers. NEWLIFE MEDICALS USA INC leads with $37.1K in import value; the top 5 suppliers together control 84.0% of this origin. Leading Indian buyers include AUROBINDO PHARMA LIMITED. This corridor reflects India's pharmaceutical import demand for acyclovir — a diversified sourcing base with multiple active suppliers from UNITED STATES.

NEWLIFE MEDICALS USA INC is the leading Acyclovir supplier from UNITED STATES to India, with import value of $37.1K across 1 shipments. The top 5 suppliers — NEWLIFE MEDICALS USA INC, AUROBINDO PHARMA USA, INC, NEWLIFE MEDICALS (USA) INC, NEWLIFE MEDICALS (USA). INC., ESPEE BIOPHARMA & FINECHEM LLC — collectively account for 84.0% of total import value from this origin.
Ranked by import value (USD) · Indian Customs (DGFT) data
| # | Supplier | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | NEWLIFE MEDICALS USA INC | $37.1K | 1 | 38.8% |
| 2 | AUROBINDO PHARMA USA, INC | $19.8K | 1 | 20.7% |
| 3 | NEWLIFE MEDICALS (USA) INC | $12.6K | 1 | 13.2% |
| 4 | NEWLIFE MEDICALS (USA). INC. | $5.9K | 8 | 6.2% |
| 5 | ESPEE BIOPHARMA & FINECHEM LLC | $5.0K | 1 | 5.2% |
| 6 | NewLife Medicals (USA). Inc. | $4.6K | 1 | 4.9% |
| 7 | RAFF & HALL PHARMACY, | $3.7K | 1 | 3.9% |
| 8 | NEW LIFE MEDICALS (USA), INC. | $2.5K | 2 | 2.7% |
| 9 | SSS PHARMACY INC | $1.1K | 2 | 1.2% |
| 10 | AMNEAL PHARMACEUTICALS | $910 | 2 | 1.0% |
| 11 | REGIONAL PHARMACY | $872 | 2 | 0.9% |
| 12 | NOVITIUM PHARMA LLC | $612 | 19 | 0.6% |
| 13 | Apteka Rx Inc. (Amsterdam Pharma) | $471 | 1 | 0.5% |
| 14 | AMNEAL PHARMACEUTICALS OF LLC | $304 | 2 | 0.3% |
| 15 | Spring Bio Solution | $47 | 1 | 0.0% |
Ranked by import value (USD)
| # | Buyer | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | AUROBINDO PHARMA LIMITED | $49.7K | 2 | 51.9% |
| 2 | AUROBINDO PHARMA LTD | $26.8K | 11 | 28.0% |
| 3 | JAMP INDIA PHARMACEUTICALS PRIVATE LIMITED | $7.2K | 3 | 7.5% |
| 4 | JUBILANT GENERICS LIMITED | $5.0K | 1 | 5.2% |
| 5 | ZYDUS LIFESCIENCES LIMITED | $4.6K | 3 | 4.8% |
| 6 | AMNEAL PHARMACEUTICALS PRIVATE LIMITED | $1.2K | 4 | 1.3% |
| 7 | NOVITIUM LABS PRIVATE LIMITED | $612 | 19 | 0.6% |
| 8 | LAURUS LABS LIMITED | $518 | 2 | 0.5% |
| 9 | APL HEALTHCARE LIMITED | $52 | 7 | 0.1% |
Answers based on Indian Customs (DGFT) import records compiled by TransData Nexus
The top Acyclovir suppliers from UNITED STATES to India include NEWLIFE MEDICALS USA INC, AUROBINDO PHARMA USA, INC, NEWLIFE MEDICALS (USA) INC. The leading supplier is NEWLIFE MEDICALS USA INC with import value of $37.1K USD across 1 shipments. India imported Acyclovir worth $95.7K USD from UNITED STATES in total across 52 shipments.
India imported Acyclovir worth $95.7K USD from UNITED STATES across 52 shipments. Data is from Indian Customs (DGFT) records. Values are in USD.
The main Indian buyers of Acyclovir sourced from UNITED STATES include AUROBINDO PHARMA LIMITED, AUROBINDO PHARMA LTD, JAMP INDIA PHARMACEUTICALS PRIVATE LIMITED. The largest buyer is AUROBINDO PHARMA LIMITED with $49.7K in imports across 2 shipments.
The total value of Acyclovir imports from UNITED STATES to India is $95.7K USD, across 52 shipments and 15 foreign suppliers. Data source: Indian Customs (DGFT).
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
52 Verified Shipments
15 suppliers, 9 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists